tiprankstipranks
Nanobiotix (NBTX)
NASDAQ:NBTX
Holding NBTX?
Track your performance easily

Nanobiotix (NBTX) Income Statement

43 Followers

Nanobiotix Income Statement

Last quarter (Q4 2023), Nanobiotix's total revenue was €―, a decrease of ― from the same quarter last year. In Q4, Nanobiotix's net income was €―. See Nanobiotix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-€ 36.21M€ 4.78M€ 2.65M€ 2.51M€ 68.00K
Cost of Revenue
------
Gross Profit
-€ 36.21M€ 4.78M€ 10.00K€ 50.00K-
Operating Expense
-€ 62.99M€ 64.36M€ 49.81M€ 36.30M€ 46.85M
Operating Income
-€ -26.78M€ -64.36M€ -49.80M€ -36.24M€ -46.78M
Net Non Operating Interest Income Expense
-€ -6.48M€ 3.53M€ 6.36M€ 201.00K€ -4.55M
Other Income Expense
-€ 4.23M€ -3.79M€ 2.78M€ -2.46M€ 423.00K
Pretax Income
-€ -39.58M€ -57.03M€ -47.00M€ -33.58M€ -50.91M
Tax Provision
-€ 120.00K€ 10.00K€ 5.00K€ 9.00K€ 3.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-€ -39.70M€ -57.04M€ -47.00M€ -33.59M€ -50.91M
Basic EPS
-€ -1.08€ -1.64€ -1.35€ -1.38-
Diluted EPS
-€ -1.08€ -1.64€ -1.35€ -1.38-
Basic Average Shares
-€ 36.93M€ 34.85B€ 34.73B€ 24.39B-
Diluted Average Shares
-€ 36.93M€ 34.78M€ 34.82M€ 24.34M-
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-----€ 9.44M
Total Expenses
-€ 62.99M€ 64.36M€ 49.81M€ 36.30M€ 46.85M
Net Income From Continuing And Discontinued Operation
-€ -39.70M€ -57.04M€ -47.00M€ -33.59M€ -50.91M
Normalized Income
-€ -29.09M---€ -51.34M
Interest Expense
-----€ 4.79M
EBIT
-€ -31.88M€ -51.43M€ -46.62M€ -33.58M€ -46.12M
EBITDA
-€ -30.37M€ -49.93M€ -45.06M€ -31.83M€ -44.35M
Currency in EUR

Nanobiotix Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis